Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma

<div>FCRLs expression in CM patients and the association with promoter DNA methylation. (a) The baseline of eight FCRLs in CM patients in the TCGA-CM cohort. (b) The different expression of FCRLs in patients with high (≥3 cm) or low (&lt;3 cm) Breslow’s depth. (c) The association of FCRLs and DNA methylation at their promoter region.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma 